FGFR2 gene amplification and clinicopathological features in gastric cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 738 citations · Full text

Medicine, Cancer Biology, Oncology +17

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

David Cappellen, Catherine De Oliveira, David Ricol et al. · Nature Genetics · 1999 · 705 citations

Medicine, Molecular Genetics, Oncology +14

Drug-sensitive <i>FGFR2</i> mutations in endometrial carcinoma

Amit Dutt, Helga B. Salvesen, Tzu-Hsiu Chen et al. · Proceedings of the National Academy of Sciences · 2008 · 345 citations · Full text

Medicine, Cancer Biology, Oncology +17

Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.

Dipak Kumar Giri, F. Ropiquet, Michael Ittmann · PubMed · 1999 · 284 citations

Medicine, Molecular Biology, Oncology +17